|
|
Blood, 15 August 2006, Vol. 108, No. 4, pp. 1243-1250.
Prepublished online as a Blood First Edition Paper on April 18, 2006; DOI 10.1182/blood-2005-11-4447.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration
Benoit Favier,
Antoine Alam,
Pauline Barron,
Jacques Bonnin,
Patricia Laboudie,
Pierre Fons,
Marie Mandron,
Jean-Pascal Herault,
Gera Neufeld,
Pierre Savi,
Jean-Marc Herbert, and
Françoise Bono
From the Sanofi-Synthelabo Research, Angiogenesis and Thrombosis Department, Toulouse, France; and the Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.
Neuropilin 2 (NRP2) is a receptor for the vascular endothelial growth factor (VEGF) and the semaphorin (SEMA) families, 2 unrelated ligand families involved in angiogenesis and neuronal guidance. NRP2 specifically binds VEGF-A and VEGF-C, although the biological relevance of these interactions in human endothelial cells is poorly understood. In this study, we show that both VEGF-A and VEGF-C induce the interaction of NRP2 with VEGFR-2. This interaction correlated with an enhancement of the VEGFR-2 phosphorylation threshold. Overexpression of NRP2 in primary human endothelial cells promoted cell survival induced by VEGF-A and VEGF-C. In contrast, SEMA3F, another ligand for NRP2, was able to inhibit human endothelial cell survival and migration induced by VEGF-A and VEGF-C. Moreover, a siRNA targeting specifically NRP2 was a potent inhibitor of human endothelial cell migration induced by VEGF-A and VEGF-C. Thus, our data indicate that NRP2 acts as a coreceptor that enhances human endothelial cell biological responses induced by VEGF-A and VEGF-C.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E.-M. Hedlund, K. Hosaka, Z. Zhong, R. Cao, and Y. Cao
Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature
PNAS,
October 13, 2009;
106(41):
17505 - 17510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. De Smet, I. Segura, K. De Bock, P. J. Hohensinner, and P. Carmeliet
Mechanisms of Vessel Branching: Filopodia on Endothelial Tip Cells Lead the Way
Arterioscler Thromb Vasc Biol,
May 1, 2009;
29(5):
639 - 649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bagri, M. Tessier-Lavigne, and R. J. Watts
Neuropilins in Tumor Biology
Clin. Cancer Res.,
March 15, 2009;
15(6):
1860 - 1864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Pacheco-Pinedo, M. T. Budak, U. Zeiger, L. H. Jorgensen, S. Bogdanovich, H. D. Schroder, N. A. Rubinstein, and T. S. Khurana
Transcriptional and functional differences in stem cell populations isolated from extraocular and limb muscles
Physiol Genomics,
March 3, 2009;
37(1):
35 - 42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Larrivee, C. Freitas, S. Suchting, I. Brunet, and A. Eichmann
Guidance of Vascular Development: Lessons From the Nervous System
Circ. Res.,
February 27, 2009;
104(4):
428 - 441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Kunduzova, N. Alet, N. Delesque-Touchard, L. Millet, I. Castan-Laurell, C. Muller, C. Dray, P. Schaeffer, J. P. Herault, P. Savi, et al.
Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes
FASEB J,
December 1, 2008;
22(12):
4146 - 4153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Saban, M. R. Saban, J. Maier, B. Fowler, M. Tengowski, C. A. Davis, X.-R. Wu, D. J. Culkin, P. Hauser, J. Backer, et al.
Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients
Am J Physiol Renal Physiol,
December 1, 2008;
295(6):
F1613 - F1623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Airoldi, C. Cocco, N. Giuliani, M. Ferrarini, S. Colla, E. Ognio, G. Taverniti, E. Di Carlo, G. Cutrona, V. Perfetti, et al.
Constitutive expression of IL-12R{beta}2 on human multiple myeloma cells delineates a novel therapeutic target
Blood,
August 1, 2008;
112(3):
750 - 759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sulpice, J. Plouet, M. Berge, D. Allanic, G. Tobelem, and T. Merkulova-Rainon
Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity
Blood,
February 15, 2008;
111(4):
2036 - 2045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Gray, G. Van Buren, N. A. Dallas, L. Xia, X. Wang, A. D. Yang, R. J. Somcio, Y. G. Lin, S. Lim, F. Fan, et al.
Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver
J Natl Cancer Inst,
January 16, 2008;
100(2):
109 - 120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Curreli, Z. Arany, R. Gerardy-Schahn, D. Mann, and N. M. Stamatos
Polysialylated Neuropilin-2 Is Expressed on the Surface of Human Dendritic Cells and Modulates Dendritic Cell-T Lymphocyte Interactions
J. Biol. Chem.,
October 19, 2007;
282(42):
30346 - 30356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Airoldi, E. Di Carlo, C. Cocco, G. Taverniti, T. D'Antuono, E. Ognio, M. Watanabe, D. Ribatti, and V. Pistoia
From the Cover: Endogenous IL-12 triggers an antiangiogenic program in melanoma cells
PNAS,
March 6, 2007;
104(10):
3996 - 4001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cariboni, J. Hickok, S. Rakic, W. Andrews, R. Maggi, S. Tischkau, and J. G. Parnavelas
Neuropilins and Their Ligands Are Important in the Migration of Gonadotropin-Releasing Hormone Neurons
J. Neurosci.,
February 28, 2007;
27(9):
2387 - 2395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hochman, A. Castiel, J. Jacob-Hirsch, N. Amariglio, and S. Izraeli
Molecular Pathways Regulating Pro-migratory Effects of Hedgehog Signaling
J. Biol. Chem.,
November 10, 2006;
281(45):
33860 - 33870.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|